{"id":14785,"date":"2025-10-16T12:14:53","date_gmt":"2025-10-16T06:44:53","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=14785"},"modified":"2025-10-17T13:03:44","modified_gmt":"2025-10-17T07:33:44","slug":"rubicon-research-ipo-makes-strong-market-debut-with-28-percent-premium","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/rubicon-research-ipo-makes-strong-market-debut-with-28-percent-premium\/","title":{"rendered":"Rubicon Research IPO: Shares List at Impressive 28% Premium Above Issue Price Amid Heavy Subscription"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]Pharmaceutical formulation firm Rubicon Research Ltd made an impressive debut on Dalal Street on Thursday, October 16, 2025. Shares of Rubicon<\/a> opened at \u20b9620.10 on the BSE and \u20b9620 on the NSE, reflecting a premium of nearly 28% over the issue price of \u20b9485 per share.<\/p>\n

The strong listing followed an overwhelming investor response during the IPO subscription window, highlighting robust demand across institutional and retail categories. The \u20b91,377.5-crore IPO marked one of the most sought-after pharmaceutical listings of the year, attracting significant attention from both domestic and global investors.<\/p>\n

<\/span>Record-Breaking Investor Response<\/strong><\/span><\/h2>\n

The Rubicon Research IPO<\/a> was subscribed 103.9 times, receiving bids for over 1.7 billion shares against 16.45 million shares available for subscription, according to NSE data.<\/p>\n

Among investor categories, Qualified Institutional Buyers (QIBs) led the charge with 130.26 times subscription, while Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) subscribed 97.61 times and 35.47 times, respectively.<\/p>\n

In total, the IPO drew over 31.4 lakh applications, representing bids worth \u20b982,900 crore, making it one of the most successful public offerings of FY26.<\/p>\n

The issue, which opened on October 9 and closed on October 13, was priced in the range of \u20b9461\u2013\u20b9485 per share with a lot size of 30 shares. Ahead of the opening, the company raised \u20b9619 crore from anchor investors, including global and domestic heavyweights such as Goldman Sachs, HDFC Mutual Fund<\/a>, Fidelity Funds, ICICI Prudential MF<\/a>, Kotak Mahindra Mutual Fund<\/a>, Amansa Holdings, and Aranda Investments Private Limited, among others.<\/p>\n


\n\"\"
\n<\/a><\/p>\n